Metastatic melanoma is a type of skin cancer that typically originates in the skin and can spread to other organs such as the lymph nodes and lungs. It is estimated that between 2% to 4% of the population is affected by metastatic melanoma. Metastatic melanoma is usually caused by the exposure to ultraviolet radiation from the sun or artificial sources, such as tanning beds. As a result, people who spend a lot of time outdoors or who use tanning beds are at a higher risk of developing this type of cancer. Symptoms of metastatic melanoma vary depending on the stage the cancer is in and the organs it has spread to. Common symptoms include changes in the size, shape or color of the existing melanoma lesions, or the development of new moles. Metastatic melanoma can also cause pain and swelling in areas such as the lymph nodes or other organs. Diagnosis of metastatic melanoma usually involves a physical exam and imaging tests, such as x-rays or computed tomography (CT) scans, to look for evidence of spread. A biopsy can also be used to confirm the presence of melanoma. Treatment for metastatic melanoma typically involves a combination of surgical removal of the primary tumor, chemotherapy, and/or targeted or immunotherapy. The goal of treatment is to prevent the cancer from spreading and to find a way to keep it from recurring. As with other types of cancer, early detection is key in treating metastatic melanoma. If you notice any changes in the appearance of moles or other skin lesions, see a physician right away. Regular skin check-ups and examination by a dermatologist is an important step in the prevention and early detection of melanoma and other types of skin cancer.
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Paraneoplastic Autoimmune Multiorgan Syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Art, skin, and dermatology: Interdisciplinary perspectives
Dechelette Corinne, La Peau Autrement, France
Title : Personalized and Precision Medicine as a unique avenue to have the healthcare model renewed to secure the national biosafety: Advanced skincare solutions in individualized cosmetology, reconstructive plastic surgery and the modern beauty
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Lymphoproliferative diseases in the practice of a dermatologist
Sergeeva Irina, Novosibirsk State University, Russian Federation
Title : Assessing efficacy and safety of hair growth products in a clinical design using qualitative and quantitative techniques
Nalini Kaul, Princeton Consumer Research, Canada
Title : Integrating personalized and precision medicine into dermatology clinical practice securing its potential to get skin diseases cured and to revolutionize dermatooncology
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, The Clinic of Plastic Surgery and Aesthetic Dermatology, Totalcharm, Georgia
Title : How a combined use of stem cells and laser technologies for face and neck rejuvenation can reduce patients’request for surgical correction
Elena Giardini, Private Practice, Italy
Title : Demographic and clinical profile of allergic contact dermatitis patients who tested positive with metal allergy from a tertiary hospital: A 12 year retrospective study
Camille Ysabel V Bautista, Jose R. Reyes Memorial Medical Center, Philippines